Yeji X
Nashville, US Β· 1 known investors
Yeji X builds an AI layer that reads patients' EHR, imaging, and claims data to identify individuals heading toward avoidable cost events and recommend the next best intervention. It serves independent, physician-led value-based care organizations and ACOs carrying two-sided risk in the US healthcare market.
Also known as YejiX Β· YeziX Β· μμ§μμ€
Founders & leadership


Board

Investors Β· 1
Company profile
researched Aug 2026Yeji X is a medical AI company that reads a patient population's electronic health record, medical imaging (PACS) and claims data together to rank patients by who is heading toward an avoidable cost event, and to attach a recommended next best intervention and timing to each name on the resulting worklist. The product is positioned for organizations carrying two-sided risk, giving both executives and care managers a prioritized view of which beneficiaries to reach, what action to take, and when. The company states that its system integrates with existing EHRs, imaging archives, claims files and other healthcare data sources and returns intelligence into current care-management workflows rather than replacing them.
The company's core pipeline is a heart-failure readmission risk prediction algorithm built on multimodal AI that jointly analyzes EHR data and medical images to support early detection of disease and to predict post-discharge deterioration and readmission risk. In the post-discharge phase, the solution is described as drawing on remote patient monitoring and wearable device data to identify high-risk patients so that limited clinical staff and resources can be allocated first to them. Management frames this as the starting point of a "continuum of care" extending from the hospital to the home and community, with the longer-term goal of becoming an infrastructure layer that improves hospital financial performance and operational efficiency.
Yeji X also conducts medical imaging research: company-affiliated authors published work on CHASE, a single-stage hierarchical chest X-ray classification framework using a Vision Transformer backbone and a clinically grounded three-level taxonomy of 9 anatomical regions, 17 sub-regions and 28 findings, with code released publicly.
Business model
Yeji X sells software to healthcare provider organizations, positioning its risk-prediction and intervention-recommendation system as a layer that plugs into existing EHR, imaging and claims systems and feeds prioritized worklists back into care-management workflows. The company describes an ambition to become a core infrastructure component within US hospital systems, tying its value proposition to hospitals' financial structure, cost reduction and operational efficiency alongside clinical outcomes.
Traction
Yeji X is recruiting pilot partners among value-based organizations including independent ACOs in the REACH and LEAD models. It was selected for the Ministry of SMEs and Startups' TIPS Global Track, which provides up to KRW 1.2 billion in R&D funding over three years and requires at least KRW 300 million of investment from a TIPS operator plus evidence of global expansion such as overseas investment, revenue, an overseas subsidiary or signed purchase agreements. It was also selected for the Nashville Entrepreneur Center's Project Healthcare 2026 Spring Cohort, a 22-company healthcare accelerator, and presented among 13 companies in the Healthcare Innovation showcase at Nashville Entrepreneur Day in May 2026.
Latest developments
In 2026 the company was selected for the Project Healthcare 2026 Spring Cohort run by the Nashville Entrepreneur Center and presented at the Nashville Entrepreneur Day Healthcare Innovation showcase in May 2026. It was selected for the TIPS Global Track on the recommendation of Kakao Ventures, which led its seed investment, and strengthened its scientific advisory board with KAIST professor and former Google Health researcher Yoonjae Choi, following the earlier appointment of Seoul National University professor Chang-Min Park. Company-affiliated researchers also published the CHASE chest X-ray classification framework in August 2026.
βΈFull profile β market position, technology, go-to-market, geography, history, risks & controversies
Market position
Yeji X positions itself in the US value-based care analytics market, arguing that most value-based organizations cannot reliably identify which patients are closest to an avoidable admission because EHR, claims and imaging data sit in separate systems and worklists are typically built from only one of them. It targets Nashville, a market described as home to more than 900 healthcare companies including HCA Healthcare generating roughly $97 billion in annual revenue, with Oracle announcing a headquarters relocation there to expand its healthcare data business.
The company's stated differentiator is reading EHR, claims and imaging data together for every patient rather than ranking risk from a single data source, and pairing the resulting risk ranking with a specific recommended intervention and timing in one output.
Technology
The platform is based on multimodal AI that jointly analyzes electronic health records and medical imaging, extended with claims data and, in the post-discharge setting, remote patient monitoring and wearable device data. Outputs are a risk ranking across a patient roster plus a recommended next best intervention and timing per patient. Integration is with existing EHRs, PACS imaging systems and claims sources. In published research, company authors describe CHASE, a hierarchical multi-label chest X-ray classification framework built on a shared Vision Transformer backbone that jointly optimizes multi-level supervision, global KL probability alignment across levels, and a hierarchy-violation penalty over a three-level taxonomy of 9 regions, 17 sub-regions and 28 findings, reporting 74.26% probabilistic hierarchy consistency and level-wise attention maps for anatomical grounding.
Go-to-market
The company recruits pilot partners directly through its website, targeting a selected group of value-based organizations, and has built its US presence in Nashville, Tennessee to gather feedback from local hospital customers from the product development stage. It chose the Nashville ecosystem rather than Boston or Silicon Valley because of the local concentration of value-based care and healthcare IT companies, and joined the Nashville Entrepreneur Center's Project Healthcare accelerator, which provides direct access to decision-makers at large hospital systems, investors and insurers plus support for technology validation and pilot projects. The company also presented in the Healthcare Innovation showcase at Nashville Entrepreneur Day in May 2026.
Value-based care organizations carrying two-sided risk, including independent accountable care organizations participating in the REACH and LEAD models, hospital systems, and their executives and care management teams.
Geography
US headquarters in Nashville, Tennessee, chosen as the company's first US base; a Seoul, South Korea location appears on company-affiliated research publications, and the company participates in Korean government startup programs administered by the Ministry of SMEs and Startups.
History
Yeji X operates from a US headquarters in Nashville, Tennessee, with a Korean corporate presence and Seoul-based research staff. It raised a seed round led by Kakao Ventures with participation reported from Schmidt, and on that recommendation was later selected for the TIPS Global Track. In 2026 it joined the Nashville Entrepreneur Center's Project Healthcare accelerator and expanded its scientific advisory board with Seoul National University professor Chang-Min Park and KAIST professor Yoonjae Choi.
Risks & controversies
Company materials describe pilots and program selections rather than commercial deployments at scale, and public sourcing includes no disclosed revenue, customer counts or independent clinical validation of the readmission prediction pipeline. Publicly cited product statistics, such as a 64% reduction in population risk after intervention, appear in illustrative interface examples on the company's own website.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Timeline Β· 5
launches, deals, and filingsResearchers affiliated with Yeji X (Seoul, South Korea) published CHASE, a single-stage hierarchical multi-label chest X-ray classification framework using a Vision Transformer backbone and a three-level clinical taxonomy of 9 regions, 17 sub-regions and 28 findings, with code released on GitHub.
Yeji X was one of 13 companies presenting in the Healthcare Innovation showcase at the third Nashville Entrepreneur Day at GEODIS Park, attended by more than 1,200 registrants.
Yeji X was selected for the Nashville Entrepreneur Center's healthcare-specialized accelerator, a 22-company cohort giving participants access to executives at hospital systems including HCA Healthcare, investors and insurers, plus support for technology validation and pilot projects.
Yeji X was selected for the TIPS Global Track, a Korean government program supporting overseas expansion of technology startups that provides up to KRW 1.2 billion in R&D funding over three years. The selection came on the recommendation of Kakao Ventures, which led the company's seed investment, and was based in part on the US market potential of its heart failure readmission risk prediction algorithm.
Yeji X appointed KAIST professor and former Google Health researcher Yoonjae Choi to its scientific advisory board to support development of a standardized prediction platform that processes complex EHR data across diverse healthcare environments.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
βΈResearch sources Β· 8
primary sources listed
- Yeji Xyejix.ai Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Yeji X do?
- Yeji X builds multimodal AI that combines EHR, imaging and claims data to predict patient risk and recommend interventions for value-based care.
- Who founded Yeji X?
- Yeji X was founded by David Jung.
- Who are Yeji X's investors?
- Yeji X's investors include Kakao Ventures.
- Where is Yeji X headquartered?
- Yeji X is headquartered in Nashville, US.
